Last reviewed · How we verify

NCT06034457: WW Clinic

Testing the Effectiveness of WW Clinic GLP1

Completed Results posted Last updated 19 December 2025
What this trial tests

trial in Weight Loss in 180 participants. Completed in 17 October 2024.

Timeline
18 January 2024
Primary endpoint
17 October 2024
17 October 2024

Quick facts

Lead sponsorThe Cleveland Clinic
StatusCompleted
Study typeOBSERVATIONAL
Enrollment180
Start date18 January 2024
Primary completion17 October 2024
Estimated completion17 October 2024
Sites1 location across United States

Conditions studied

Sponsor

The Cleveland Clinic

Who can join

18 and older, any sex, with Weight Loss or Obesity. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change in Weight in Pounds From Week 0 to Week 24 Primary · 0 to 24 weeks

Effect of WW GLP1 behavioral program + WW Clinic (formerly known as Sequence) on absolute change of weight loss at 24 weeks.

GroupValue95% CI
Single Arm-27.41± 14.86
Weight Loss Percentage Change From Week 0 to Week 24 Secondary · 0 to 24 weeks

Effect of WW + WW Clinic (formerly known as Sequence) on weight loss and % reaching 5, 10, 15, 20 % body weight loss at 24 weeks.

Number of participants with >= 5% weight loss at 24 weeks
GroupValue95% CI
Single Arm161
Number of participants with >= 10% weight loss at 24 weeks
GroupValue95% CI
Single Arm121
Number of participants with >= 15% weight loss at 24 weeks
GroupValue95% CI
Single Arm81
Number of participants with >= 20% weight loss at 24 weeks
GroupValue95% CI
Single Arm20
Blood Pressure Changes (Systolic and Diastolic) in mmHg From Week 0 to Week 24 Secondary · 0 to 24 weeks

Effect of WW + WW Clinic (formerly known as Sequence) on absolute change of blood pressure at 24 weeks

Change in diastolic blood pressure at 24 weeks
GroupValue95% CI
Single Arm-5.66± 13.29
Change in systolic blood pressure at 24 weeks
GroupValue95% CI
Single Arm-11.17± 14.96
Change in Quality of Life Scores From Week 0 to Week 24 Secondary · 0 to 24 weeks

Effect of WW + WW Clinic (formerly known as Sequence) on absolute change of Quality of Life (QOL) scores using "Impact of Weight on Quality of Life-Lite Scale" Scale Name + Description of scale: "Impact of Weight on Quality of Life-Lite (IWQOL-Lite) Is a validated, 31-item, self-report measure of obesity-specific quality of life in adults. There are five domains include physical function, self-esteem, sexual life, public distress and work. Scale Ranges (min, max): 0-100 Description of scoring: Higher scores represent lower quality of life (i.e., greater impact of obesity on quality of life).

Physical Function
GroupValue95% CI
Single Arm-20.13± 17.79
Self-Esteem
GroupValue95% CI
Single Arm-27.98± 22.5
Sexual Life
GroupValue95% CI
Single Arm-18.27± 23.1
Public Distress
GroupValue95% CI
Single Arm-11.44± 17.99
Work
GroupValue95% CI
Single Arm-12.08± 19.81
Total Score
GroupValue95% CI
Single Arm-19.19± 13.42
Changes in Well-being Scores From Week 0 to Week 24 Secondary · 0 to 24 weeks

Effect of WW + WW Clinic (formerly known as Sequence) on absolute change of Well-being at 24 weeks using "WHO Well-Being Index 5" Scale Name + Description of scale: "Well-being Index 5 (WHO-5)" is a 5-item questionnaire that assesses subjective well-being through five statements about feeling cheerful, calm, active, interested and rested over the past two weeks. Scale Ranges (min, max) 0-25 Description of scoring: Lower scores indicate worse overall well-being, higher scores indicate better overall well-being. A positive mean change indicates improvement in well-being.

GroupValue95% CI
Single Arm2.92± 3.98
Changes in Disordered Eating Scores From Week 0 to Week 24 Secondary · 0 to 24 weeks

Effect of WW + WW Clinic (formerly known as Sequence) on absolute change of Disordered Eating at 24 weeks using "Eating Disorder Examination-Questionnaire" Scale Name + Description of scale: "Eating Disorder Examination-Questionnaire (EDE-Q)" is a 28-item self-report questionnaire, adapted from the semi-structured interview, the Eating Disorder Examination (EDE). The questionnaire is designed to assess the range, frequency and severity of behaviors associated with a diagnosis of an eating disorder. Scale Ranges (min, max): 0-6 Description of scoring: Lower scores indicate less problematic eat

Restraint Score
GroupValue95% CI
Single Arm0.09± 1.74
Eating Concerns Score
GroupValue95% CI
Single Arm-0.75± 1.28
Shape Concern Score
GroupValue95% CI
Single Arm-1.04± 1.07
Weight Concern Score
GroupValue95% CI
Single Arm-0.76± 0.8
Global Score
GroupValue95% CI
Single Arm-0.61± 0.95
Changes in Strength Training Scores From Week 0 to Week 24 Secondary · 0 to 24 weeks

Effect of WW + WW Clinic (formerly known as Sequence) on absolute change of Strength Training Behavior at 24 weeks using the "Strength Training Behavior Scale" Scale Name + Description of scale: "Stage of Change for Strength Training" Strength training is defined as all activities that serve to enhance muscle strength and endurance (free weights, body weight exercises, etc.) Regular resistance training is described as engaging in these activities at least two times per week. Scale Ranges (min, max): 0-7 Description of scoring: Lower scores indicate less days strength training. Higher scores e

GroupValue95% CI
Single Arm0.48± 1.37
Changes in Stress Scores From Week 0 to Week 24 Secondary · 0 to 24 weeks

Effect of WW + WW Clinic (formerly known as Sequence) on absolute change of Stress at 24 weeks using the "Perceived Stress Scale" Scale Name + Description of scale: "Perceived Stress Scale, PSS-10" is a self-report scale that asks about feelings and thoughts related to stressful things during the last month. Scale Ranges (min, max): 10-50 Description of scoring: Higher scores indicate more perceived stress and lower scores indicate less perceived stress. A negative mean change indicates improvement in perceived stress.

GroupValue95% CI
Single Arm-2.66± 6.51
Changes in Emotional Eating Scores From Week 0 to Week 24 Secondary · 0 to 24 weeks

Effect of WW + WW Clinic (formerly known as Sequence) on absolute change of Emotional Eating scores using the "Palatable Eating Motives Scale-Coping Subscale" Scale Name + Description of scale: "Palatable Eating Motives Scale - Coping Subscale (PEMs-Coping)" is a four-item coping subscale of the PEMs self-report that measures eating behavior as a method of coping with problems and negative feelings. Scale Ranges (min, max): 4-20 Description of scoring: Lower scores indicate lower frequency of eating as a method of coping with problems and negative feelings. Higher scores indicate higher frequ

GroupValue95% CI
Single Arm-3.99± 4.79
Changes in UnHealthy Habits Strength Scores From Week 0 to Week 24 Secondary · 0 to 24 weeks

Effect of WW + WW Clinic (formerly known as Sequence) on absolute change of Unhealthy Habits scores using "Self-Reported Behavioral Automaticity Index" Scale Name + Description of scale: "Self-Reported Behavioral Automaticity Index (SRBAI)-Unhealthy Habits Subscale" is a self-report measure to assess how automatic or habitual certain behaviors are, often used to understand unhealthy habits. Unhealthy habits included are eating sugary foods, fried foods and drinking sugary drinks. Scale Ranges (min, max): 1-7 Description of scoring: Lower scores indicate less automatic or habitual unhealthy ha

Sugary Foods
GroupValue95% CI
Single Arm-1.64± 1.86
Fried Foods
GroupValue95% CI
Single Arm-1.13± 1.81
Drinking
GroupValue95% CI
Single Arm-0.83± 1.66
Changes in Healthy Habits Strength Scores From Week 0 to Week 24 Secondary · 0 to 24 weeks

Effect of WW + WW Clinic (formerly known as Sequence) on absolute change of Habit Strength scores using the "Self-Reported Behavioral Automaticity Index for Healthy Habits" Scale Name + Description of scale: "Self-Reported Behavioral Automaticity Index (SRBAI) Healthy Habits Subscale" is a self-report measure to assess how automatic or habitual certain behaviors are, often used to understand healthy habits. Healthy habits included are portion control, food tracking, protein content, eating vegetables, weighing self, physical activity, positive self-talk after a setback, arranging kitchen so he

Portion
GroupValue95% CI
Single Arm1.72± 1.68
Tracking
GroupValue95% CI
Single Arm0.55± 1.86
Points
GroupValue95% CI
Single Arm1.24± 1.82
Vegetables
GroupValue95% CI
Single Arm0.48± 1.4
Weighing
GroupValue95% CI
Single Arm1.29± 2.01
Physically
GroupValue95% CI
Single Arm1.02± 1.57
Self-Talk
GroupValue95% CI
Single Arm0.82± 1.74
Healthy Food
GroupValue95% CI
Single Arm0.97± 1.79
Changes in Weight Bias Internalization Scores From Week 0 to Week 24 Secondary · 0 to 24 weeks

Effect of WW + WW Clinic (formerly known as Sequence) on absolute change of Weight Bias Internalization scores using "Weight Bias Internalization Scale" Scale Name + Description of scale: "Weight Bias Internalization Scale, WBIS-2F" is a 13-item measure developed to assess weight related self-stigma. Scale Ranges (min, max): 13-91 Description of scoring: Lower scores indicate more weight related self-stigma, higher scores indicate less weight related self-stigma. A negative mean change indicates a decrease in weight related self-stigma.

GroupValue95% CI
Single Arm-7.12± 9.83

Sponsor's own description

The study objective is to evaluate the efficacy of the WeightWatchers (WW) GLP-1 behavioral program + WW Clinic (formerly known as Sequence medical weight management program) on weight loss and related outcomes. Participants will be invited to take part and answer surveys at 0, 12 and 24 weeks.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Psychosocial Outcomes in Telemedicine and Long-Acting Incretin-Specific Behavioral Intervention.
    Heinberg LJ, Lee AM, Foster GD, Zajichek A, et al · · 2026 · PMID 42256457 · DOI 10.1002/osp4.70149
  2. Effectiveness of Telemedicine Prescribing and a Long-Acting Obesity Medication Behavioral Program: A 24-Week Single-Arm Study.
    Heinberg LJ, Lee AM, Foster GD, DiVita A, et al · · 2025 · PMID 41253738 · DOI 10.1002/oby.70056

Verify or expand the search:

Other recruiting trials for Weight Loss

Currently open trials in the same condition.

Other The Cleveland Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06034457.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing